» Articles » PMID: 29727510

Chronic Liver Injury Promotes Hepatocarcinoma Cell Seeding and Growth, Associated with Infiltration by Macrophages

Overview
Journal Cancer Sci
Specialty Oncology
Date 2018 May 5
PMID 29727510
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Ninety percent of hepatocarcinoma (HCC) develops in a chronically damaged liver. Interactions between non-tumor stromal components, especially macrophages, and cancer cells are still incompletely understood. Our aim was to determine whether a chronically injured liver represents a favorable environment for the seeding and growth of HCC cells, and to evaluate the potential roles of macrophages infiltrated within the tumor. HCC cells were injected into the liver in healthy mice (healthy liver group [HL]) and in mice chronically treated with carbon tetrachloride (CCl ) for 7 weeks (CCl 7w group). Livers were examined for the presence of tumor 2 weeks post-injection. Tumor and non-tumor tissues were analyzed for macrophage infiltration, origin (monocytes-derived vs resident macrophages) and polarization state, and MMP production. Fifty-three percent of mice developed neoplastic lesion in the HL group whereas a tumor lesion was found in all livers in the CCl 7w group. Macrophages infiltrated more deeply the tumors of the CCl 7w group. Evaluation of factors involved in the recruitment of macrophages and of markers of their polarization state was in favor of prominent infiltration of M2 pro-tumor monocyte-derived macrophages inside the tumors developing in a chronically injured liver. MMP-2 and -9 production, attributed to M2 pro-tumor macrophages, was significantly higher in the tumors of the CCl 7w group. In our model, chronic liver damage promotes cancer development. Our results suggest that an injured background favors the infiltration of M2 pro-tumor monocyte-derived macrophages. These secrete MMP-2 and MMP-9 that promote tumor progression.

Citing Articles

Biological impact and therapeutic implication of tumor-associated macrophages in hepatocellular carcinoma.

Li D, Zhang T, Guo Y, Bi C, Liu M, Wang G Cell Death Dis. 2024; 15(7):498.

PMID: 38997297 PMC: 11245522. DOI: 10.1038/s41419-024-06888-z.


Mechanisms of tumor-associated macrophages affecting the progression of hepatocellular carcinoma.

Yuan Y, Wu D, Li J, Huang D, Zhao Y, Gao T Front Pharmacol. 2023; 14:1217400.

PMID: 37663266 PMC: 10470150. DOI: 10.3389/fphar.2023.1217400.


Intratumoral PPT1-positive macrophages determine immunosuppressive contexture and immunotherapy response in hepatocellular carcinoma.

Weng J, Liu S, Zhou Q, Xu W, Xu M, Gao D J Immunother Cancer. 2023; 11(6).

PMID: 37385725 PMC: 10314632. DOI: 10.1136/jitc-2022-006655.


Systemic and molecular analysis dissect the red ginseng induction of apoptosis and autophagy in HCC as mediated with AMPK.

Kim Y, Bak S, Lee W, Bae S, Lee E, Yang J J Ginseng Res. 2023; 47(3):479-491.

PMID: 37252280 PMC: 10214298. DOI: 10.1016/j.jgr.2023.02.002.


RHBDF2 is correlated with immune infiltrates in hepatocellular carcinoma and may have potential as a biomarker.

Gong H, Xie H, Huangfu Z, Zhang S, Tang Y, Xiao M FEBS Open Bio. 2023; 13(5):881-897.

PMID: 36943228 PMC: 10153346. DOI: 10.1002/2211-5463.13598.


References
1.
Singh S, Fujii L, Murad M, Wang Z, Asrani S, Ehman R . Liver stiffness is associated with risk of decompensation, liver cancer, and death in patients with chronic liver diseases: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2013; 11(12):1573-84.e1-2. PMC: 3900882. DOI: 10.1016/j.cgh.2013.07.034. View

2.
Schneider C, Teufel A, Yevsa T, Staib F, Hohmeyer A, Walenda G . Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer. Gut. 2012; 61(12):1733-43. PMC: 4533880. DOI: 10.1136/gutjnl-2011-301116. View

3.
Kang T, Yevsa T, Woller N, Hoenicke L, Wuestefeld T, Dauch D . Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature. 2011; 479(7374):547-51. DOI: 10.1038/nature10599. View

4.
Theret N, Musso O, Turlin B, Lotrian D, Bioulac-Sage P, Campion J . Increased extracellular matrix remodeling is associated with tumor progression in human hepatocellular carcinomas. Hepatology. 2001; 34(1):82-8. DOI: 10.1053/jhep.2001.25758. View

5.
Zhang Q, Chen X, Zhou J, Zhang L, Zhao Q, Chen G . CD147, MMP-2, MMP-9 and MVD-CD34 are significant predictors of recurrence after liver transplantation in hepatocellular carcinoma patients. Cancer Biol Ther. 2006; 5(7):808-14. DOI: 10.4161/cbt.5.7.2754. View